Delivery Order SPE2DB25D2204-SPE2DB25FTGNY
Award Date 5/30/25
Potential Completion Date 6/23/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,425.95 to AmerisourceBergen Drug Corp for ESBRIET 801 mg tablets (90-count supply) on October 27, 2025, with completion expected by November 18, 2025. This firm fixed-price delivery order was awarded competitively without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,425.95 for 90 tablets of Esbriet 801 mg, with a completion date of June 24, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Esbriet 801 mg tablets (90-count units) with a contract ceiling value of $3,425.95. This non-set-aside, competitively awarded delivery order carries firm fixed pricing and is scheduled for completion by June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,425.95 for 90 tablets of ESBRIET 801 MG, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of September 9, 2025. The contract carries no set-aside designation, indicating it was competed among eligible vendors meeting federal procurement standards....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ESBRIET 801 MG tablets (90-count) with a ceiling value of $6,851.90. This firm fixed-price, competitively awarded contract was issued on September 23, 2025, with an ultimate completion date of October 15, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC)...
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, was awarded a $9,934.50 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with a completion date of February 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $3,425.95 to AmerisourceBergen Drug Corp for 90 tablets of Esbriet 801 mg, a pharmaceutical product for pulmonary fibrosis treatment. This non-competitive, firm fixed-price delivery order was awarded on June 12, 2025, with an ultimate completion date of July 7, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ESBRIET 801 mg tablets (90-count units) with a ceiling value of $6,851.90 under a firm fixed-price contract type. The award was issued on April 24, 2025, with an ultimate completion date of May 15, 2025. This delivery order represents a non-competitive award made under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle designated SPE2DX...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Esbriet 267 mg tablets (270 count) under a firm fixed-price contract valued at $20,555.70, with an ultimate completion date of October 17, 2025. This non-set-aside, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical distributor within the federal medical supply chain. The order will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Esbriet 801 mg tablets (90-count package) with a ceiling value of $3,425.95. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and carries no set-aside designation, indicating it was competitively awarded. The performance location is AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate...